Current Report Filing (8-k)
03 May 2022 - 06:02AM
Edgar (US Regulatory)
0001630212
false
0001630212
2022-05-02
2022-05-02
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported):
May 2, 2022
AVALON GLOBOCARE CORP.
(Exact name of registrant as specified in its charter)
Delaware |
|
001-38728 |
|
47-1685128 |
(State or Other Jurisdiction
of Incorporation) |
|
(Commission File Number) |
|
(IRS Employer
Identification Number) |
4400
Route 9 South, Suite 3100, Freehold, New
Jersey 07728
(Address of principal executive offices) (zip code)
646-762-4517
(Registrant’s telephone number, including
area code)
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2.
below):
| ☐ | Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ☐ | Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ☐ | Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ☐ | Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
Title of each class |
|
Trading Symbols |
|
Name of each exchange on
which registered |
Common Stock, $0.0001 par value per share |
|
AVCO |
|
The Nasdaq Capital Market |
Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the
Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
☐ Emerging growth company
If an emerging growth company, indicate by check
mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 7.01 Regulation FD Disclosure.
Avalon
GloboCare Corp. (the “Company”) plans to present and/or distribute to the investment
community and utilize at various industry and other conferences the presentation slides attached hereto as Exhibit 99.1.
The furnishing of the attached
presentation is not an admission as to the materiality of any information therein. The information contained in the slides is summary
information that is intended to be considered in the context of more complete information included in the Company’s filings with
the U.S. Securities and Exchange Commission (the “SEC”) and other public announcements that the Company has made and may make
from time to time by press release or otherwise. The Company undertakes no duty or obligation to update or revise the information contained
in this report, although it may do so from time to time as its management believes is appropriate. Any such updating may be made through
the filing of other reports or documents with the SEC, through press releases or through other public disclosures. For important information
about forward looking statements, see the slide titled “Forward Looking Statements” in Exhibit 99.1 attached hereto.
The information in this Item 7.01
of this Current Report on Form 8-K and Exhibit 99.1 attached hereto shall not be deemed “filed” for purposes of Section 18
of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section or Sections 11 and 12(a)(2)
of the Securities Act of 1933, as amended. The information contained in this Item 7.01 and in the presentation attached as Exhibit
99.1 to this Current Report shall not be incorporated by reference into any filing with the SEC made by the Company, whether made before
or after the date hereof, regardless of any general incorporation language in such filing.
Item 9.01 Financial Statements and Exhibits
Exhibit No. |
|
Description |
99.1 |
|
Company Slide Presentation |
104 |
|
Cover Page Interactive Data File (embedded within the Inline XBRL document) |
SIGNATURES
Pursuant to the requirements of the Securities
and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
AVALON GLOBOCARE CORP. |
|
|
|
Dated: May 2, 2022 |
By: |
/s/ Luisa Ingargiola |
|
|
Name: Luisa Ingargiola |
|
|
Title: Chief Financial Officer |
2
Avalon GloboCare (NASDAQ:AVCO)
Historical Stock Chart
From Feb 2024 to Mar 2024
Avalon GloboCare (NASDAQ:AVCO)
Historical Stock Chart
From Mar 2023 to Mar 2024
Real-Time news about Avalon GloboCare Corporation (NASDAQ): 0 recent articles
More Avalon Globocare Corp. News Articles